GO:0006157 deoxyadenosine catabolic process: Nucleoside Breakdown, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006157 describes the chemical reactions and pathways that break down deoxyadenosine, a major DNA nucleoside, into its constituent base and sugar moieties.
• Deoxyadenosine catabolism is tightly linked to nucleotide salvage, mitochondrial DNA maintenance, and epigenetic regulation via N6-methyl-deoxyadenosine.
• Key enzymes include adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP), and deoxyribonucleoside kinases, which collectively control deoxyadenosine levels.
• Dysregulation of deoxyadenosine catabolism contributes to severe combined immunodeficiency (ADA deficiency), mitochondrial disorders, and cancer.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect the enzymatic steps and regulatory nodes of this pathway.
• EDITGENE provides end-to-end CRISPR services to generate isogenic cell models for studying deoxyadenosine catabolic process and its disease relevance.
Description
Deoxyadenosine catabolic process (GO:0006157) is the set of biochemical reactions that degrade deoxyadenosine, a deoxyribonucleoside that is a building block of DNA, into adenine and 2-deoxyribose-1-phosphate or related metabolites. This process is fundamental for maintaining cellular nucleotide pools, preventing the accumulation of toxic deoxyadenosine intermediates, and supporting mitochondrial DNA integrity. Researchers study this pathway because its dysfunction is linked to immunodeficiency, mitochondrial diseases, and cancer, and because it intersects with epigenetic marks such as N6-methyl-deoxyadenosine. Understanding the enzymes and regulatory mechanisms of deoxyadenosine catabolism is therefore critical for both basic biology and therapeutic development.
deoxyadenosine catabolic process At A Glance
| GO ID | GO:0006157 |
|---|---|
| GO term | deoxyadenosine catabolic process |
| Ontology | biological_process |
| Synonym | deoxyadenosine breakdown; deoxyadenosine catabolism; deoxyadenosine degradation; deoxyadenosine phosphorolysis |
| Major function | Breakdown of deoxyadenosine to maintain nucleotide homeostasis and prevent toxicity |
| Key enzymes | Adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP), deoxyribonucleoside kinases |
| Related pathways | Purine salvage, mitochondrial DNA repair, epigenetic regulation via N6-methyl-deoxyadenosine |
| Disease relevance | ADA deficiency (SCID), mitochondrial disorders, cancer |
What Is GO:0006157?
The deoxyadenosine catabolic process (GO:0006157) encompasses the chemical reactions and pathways that result in the breakdown of deoxyadenosine (2-deoxyribosyladenine), one of the four major nucleosides of DNA. This includes phosphorolysis, deamination, and subsequent conversions that yield free adenine and a deoxyribose derivative, which can enter central carbon metabolism.
Why Is deoxyadenosine catabolic process Important in Cell Biology?
Deoxyadenosine catabolic process is essential for cellular survival because it prevents the accumulation of deoxyadenosine and its phosphorylated derivatives, which can inhibit DNA synthesis and induce apoptosis. Moreover, this pathway is directly connected to mitochondrial DNA methylation and stability, as N6-methyl-deoxyadenosine is a recently discovered epigenetic mark in mammalian mitochondrial DNA. Defects in deoxyadenosine catabolism cause severe combined immunodeficiency (ADA deficiency) and are implicated in mitochondrial diseases and cancer, making it a target for therapeutic intervention and a focus for CRISPR-based disease modeling.
• Maintains balanced deoxyribonucleotide pools for DNA replication and repair.
• Prevents toxic accumulation of deoxyadenosine and its phosphorylated forms.
• Supports mitochondrial DNA integrity and function.
• Regulates epigenetic marks such as N6-methyl-deoxyadenosine in mitochondrial DNA.
• Dysfunction causes ADA-deficient severe combined immunodeficiency.
• Linked to mitochondrial disorders and cancer metabolism.
• Provides targets for antiviral and anticancer drug development.
• Enables CRISPR modeling of nucleotide metabolism diseases.
• Intersects with purine salvage pathways and energy homeostasis.
• Facilitates studies of nucleoside analog activation and toxicity.
What Happens During deoxyadenosine catabolic process?
Phosphorolysis of deoxyadenosine
In simple terms: The first step breaks deoxyadenosine into adenine and a sugar phosphate.
In the primary catabolic route, deoxyadenosine undergoes phosphorolysis catalyzed by purine nucleoside phosphorylase (PNP), yielding adenine and 2-deoxyribose-1-phosphate. This reaction is reversible and central to purine salvage and catabolism. The enzyme is highly specific for deoxyribonucleosides and is a key regulator of deoxyadenosine levels.
Deamination of deoxyadenosine
In simple terms: Deoxyadenosine can also be converted to deoxyinosine by removing an amino group.
Adenosine deaminase (ADA) catalyzes the deamination of deoxyadenosine to deoxyinosine, which is subsequently cleaved by PNP to hypoxanthine and 2-deoxyribose-1-phosphate. This alternative route is critical in tissues with high ADA activity, such as lymphoid cells, and its deficiency leads to accumulation of deoxyadenosine and dATP, causing lymphotoxicity.
Phosphorylation and feedback regulation
In simple terms: Deoxyadenosine can be phosphorylated, and the resulting nucleotides feedback-inhibit the pathway.
Deoxyadenosine can be phosphorylated by deoxyribonucleoside kinases to dAMP, which is then converted to dADP and dATP. High dATP levels inhibit ribonucleotide reductase and other enzymes, providing feedback regulation of the catabolic process. This interplay ensures balanced nucleotide pools and prevents toxicity.
Mitochondrial deoxyadenosine metabolism
In simple terms: Inside mitochondria, deoxyadenosine catabolism is linked to DNA methylation and stability.
Mitochondria contain enzymes for deoxyadenosine catabolism, and recent studies have identified N6-methyl-deoxyadenosine in mitochondrial DNA, suggesting a role for deoxyadenosine derivatives in epigenetic regulation. The balance between catabolism and methylation influences mitochondrial gene expression and function.
Integration with purine salvage
In simple terms: The breakdown products can be recycled back into nucleotides.
Adenine and hypoxanthine generated from deoxyadenosine catabolism can be salvaged by HGPRT and APRT to reform nucleotides, linking catabolism to salvage pathways. This integration is vital for energy homeostasis and nucleotide supply, especially in rapidly dividing cells.
Key Genes Involved in GO:0006157 deoxyadenosine catabolic process
The following genes and proteins are central to deoxyadenosine catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADA | Deaminates deoxyadenosine to deoxyinosine | ADA deficiency causes SCID; target for gene therapy |
| PNP | Phosphorolyzes deoxyadenosine to adenine and deoxyribose-1-phosphate | PNP inhibitors are anticancer and antiviral agents |
| DCK | Phosphorylates deoxyadenosine to dAMP | Activates nucleoside analogs in cancer therapy |
| NT5C | Dephosphorylates deoxyribonucleotides | Regulates nucleotide pools and catabolism |
| DGUOK | Phosphorylates deoxyguanosine and deoxyadenosine | Mutations cause mitochondrial DNA depletion syndromes |
| TK2 | Phosphorylates deoxythymidine and deoxycytidine | Mitochondrial DNA maintenance |
| RRM1 | Ribonucleotide reductase subunit, regulates dNTP pools | Feedback inhibition by dATP |
| RRM2 | Ribonucleotide reductase subunit | Target for cancer therapy |
| APRT | Salvages adenine to AMP | Links catabolism to salvage |
| HPRT1 | Salvages hypoxanthine to IMP | Lesch-Nyhan syndrome |
| AMPD1 | AMP deaminase, affects adenine pool | Energy metabolism |
| ADSL | Adenylosuccinate lyase, purine biosynthesis | Links to catabolism |
| ATIC | IMP cyclohydrolase, purine biosynthesis | Cross-talk with catabolism |
| GART | Purine biosynthesis | Regulation of nucleotide pools |
| MTHFD1 | One-carbon metabolism | Provides methyl groups for N6-methyl-deoxyadenosine |
| DNMT1 | DNA methyltransferase | Methylation of deoxyadenosine? |
| ALKBH1 | Demethylates N6-methyl-deoxyadenosine | Epigenetic regulation |
How Is deoxyadenosine catabolic process Regulated?
Deoxyadenosine catabolic process is regulated at multiple levels. Enzyme expression is controlled by transcription factors responsive to nucleotide availability, such as the purine repressor in bacteria and the MYC oncogene in mammals. Post-translational modifications, including phosphorylation of ADA and PNP, modulate their activity. Feedback inhibition by dATP on ribonucleotide reductase and by adenine on PNP ensures homeostatic control. In mitochondria, the balance between deoxyadenosine catabolism and N6-methyl-deoxyadenosine methylation is regulated by methyltransferases and demethylases such as ALKBH1. Additionally, AMPK activation by cordycepin (3'-deoxyadenosine) links energy sensing to deoxyadenosine metabolism.
deoxyadenosine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADA | Severe combined immunodeficiency (SCID) | ADA knockout iPSCs; knock-in of patient mutations |
| DGUOK | Mitochondrial DNA depletion syndrome | DGUOK knockout hepatocytes; point mutation knock-in |
| TK2 | Mitochondrial myopathy | TK2 knockout myotubes; overexpression of mutant |
| PNP | Immunodeficiency and autoimmunity | PNP knockout T cells; CRISPR point mutation |
| ALKBH1 | Mitochondrial dysfunction and epigenetic regulation | ALKBH1 knockout HeLa; tagged knock-in for imaging |
ADA deficiency and severe combined immunodeficiency (SCID)
Mutations in ADA cause accumulation of deoxyadenosine and dATP, leading to lymphotoxicity and SCID. This is a classic example of a deoxyadenosine catabolic process defect. Research models include ADA-knockout mice and patient-derived iPSCs for gene correction.
Mitochondrial DNA depletion syndromes
Defects in deoxyadenosine catabolism enzymes such as DGUOK and TK2 impair mitochondrial DNA maintenance, causing hepatocerebral and myopathic syndromes. These disorders highlight the importance of deoxyadenosine catabolism in mitochondrial function.
Cancer and nucleoside analog therapy
Deoxyadenosine catabolism influences the activation and toxicity of nucleoside analogs used in cancer and antiviral therapy. For example, cordycepin (3'-deoxyadenosine) is activated by adenosine kinase and affects AMPK signaling. Targeting catabolic enzymes can sensitize tumors to these agents.
Epigenetic regulation via N6-methyl-deoxyadenosine
N6-methyl-deoxyadenosine in mitochondrial DNA is a newly discovered epigenetic mark whose levels are influenced by deoxyadenosine catabolism. Dysregulation may contribute to mitochondrial dysfunction and disease.
From deoxyadenosine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ADA cause deoxyadenosine accumulation? | ADA knockout cell line (e.g., HEK293T) |
| How does a patient mutation in DGUOK affect mitochondrial DNA? | DGUOK point mutation knock-in via CRISPR |
| Can overexpression of PNP rescue deoxyadenosine toxicity? | PNP overexpression lentiviral model |
| Where is ALKBH1 localized in mitochondria? | ALKBH1 tagged knock-in (e.g., GFP) |
| What is the role of N6-methyl-deoxyadenosine in mitochondrial DNA? | MTHFD1 knockout and rescue |
| Does cordycepin activate AMPK via deoxyadenosine metabolism? | AMPK knockout and point mutation models |
How to Study the deoxyadenosine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Deoxyadenosine and metabolite levels | Validation of enzyme knockouts |
| CRISPR knockout screen | Gene essentiality for deoxyadenosine tolerance | Discovery of novel catabolic genes |
| N6-methyl-deoxyadenosine sequencing | Epigenetic mark distribution | Mitochondrial DNA methylation studies |
| Seahorse respirometry | Mitochondrial respiration | Functional impact of catabolic defects |
| Western blot | Protein expression of ADA, PNP, etc. | Validation of overexpression or knockout |
| qPCR | mRNA levels of catabolic genes | Transcriptional regulation studies |
| Flow cytometry | Cell viability and apoptosis | Deoxyadenosine toxicity assays |
CRISPR knockout screens
Genome-wide CRISPR knockout screens can identify genes required for deoxyadenosine catabolism and resistance to deoxyadenosine toxicity. These screens use libraries targeting all human genes and select for survival in the presence of deoxyadenosine analogs.
Metabolomics and nucleotide profiling
Liquid chromatography-mass spectrometry (LC-MS) quantifies deoxyadenosine and its metabolites, providing direct readouts of catabolic flux. This method is essential for validating enzyme knockouts and point mutations.
Sequencing of N6-methyl-deoxyadenosine
Single-base resolution sequencing methods, such as those developed for N6-methyl-deoxyadenosine, map this epigenetic mark across the genome and reveal its relationship to deoxyadenosine catabolism.
Mitochondrial functional assays
Seahorse respirometry and mitochondrial DNA copy number assays assess the impact of deoxyadenosine catabolism defects on mitochondrial function.
How CRISPR Can Be Used to Study GO:0006157 deoxyadenosine catabolic process
Knockout
CRISPR knockout of ADA, PNP, or DGUOK creates isogenic cell lines to study deoxyadenosine catabolism and its role in disease. These models recapitulate metabolic blocks and allow rescue experiments.
Point Mutation
Introducing patient-specific point mutations (e.g., in ADA or DGUOK) via CRISPR base editing or HDR enables precise modeling of enzyme deficiencies and drug responses.
Knock-in
Knock-in of tagged versions of catabolic enzymes (e.g., GFP-ALKBH1) allows live-cell imaging and proteomic analysis of localization and interactions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PNP or ADA can rescue deoxyadenosine toxicity and test sufficiency in catabolic pathways.
How EDITGENE Supports deoxyadenosine catabolic process Research
Researchers studying deoxyadenosine catabolic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide homeostasis, mitochondrial function, or disease. EDITGENE provides the CRISPR tools and services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for deoxyadenosine catabolic process research.
Frequently Asked Questions About deoxyadenosine catabolic process
What is deoxyadenosine catabolic process?
It is the breakdown of deoxyadenosine into adenine and deoxyribose-1-phosphate, maintaining nucleotide balance.
What genes are involved in deoxyadenosine catabolic process?
Key genes include ADA, PNP, DCK, DGUOK, and TK2.
What diseases are linked to deoxyadenosine catabolic process?
ADA deficiency causes SCID; DGUOK and TK2 mutations cause mitochondrial DNA depletion syndromes.
How is deoxyadenosine catabolic process regulated?
It is regulated by feedback inhibition, enzyme expression, and post-translational modifications.
What is the role of N6-methyl-deoxyadenosine in this process?
It is an epigenetic mark in mitochondrial DNA influenced by deoxyadenosine metabolism.
How can I study deoxyadenosine catabolic process using CRISPR?
Use knockout, point mutation, or knock-in models to dissect gene function and disease mechanisms.
What methods measure deoxyadenosine catabolism?
LC-MS metabolomics, CRISPR screens, and mitochondrial assays are commonly used.
Is deoxyadenosine catabolic process a drug target?
Yes, enzymes like ADA and PNP are targets for immunodeficiency and cancer therapies.
What is the connection between deoxyadenosine and cordycepin?
Cordycepin (3'-deoxyadenosine) is metabolized similarly and activates AMPK.
Where can I get CRISPR cell models for deoxyadenosine catabolic process?
EDITGENE provides custom knockout, knock-in, and overexpression models for these genes.
Conclusion
Deoxyadenosine catabolic process (GO:0006157) is a fundamental pathway that safeguards nucleotide homeostasis, mitochondrial function, and epigenetic regulation. Its dysregulation underlies severe immunodeficiencies and mitochondrial diseases, making it a compelling target for basic and translational research. CRISPR-based models are indispensable for dissecting the enzymatic steps and regulatory networks of this pathway, and EDITGENE offers comprehensive services to accelerate such studies.
References
- 1. Hao Z et al.. 2020. N(6)-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA.. Mol Cell 78(3):382-395.e8 PMID: 32183942
- 5. Hawley SA et al.. 2020. Mechanism of Activation of AMPK by Cordycepin.. Cell Chem Biol 27(2):214-222.e4 PMID: 31991096
- 6. Feng X et al.. 2024. Sequencing of N(6)-methyl-deoxyadenosine at single-base resolution across the mammalian genome.. Mol Cell 84(3):596-610.e6 PMID: 38215754
